Katharine Abbott-Banner

Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages

Hannah Metcalfe, Simon Lea, D.A. Hughes et al. · Clinical & Experimental Immunology · 2014 · 81 citations · Full text

Life Sciences, Immunology, Pathobiology +17

The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD

Dave Singh, Katharine Abbott-Banner, Thomas Bengtsson et al. · European Respiratory Journal · 2018 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma

Leif Bjermer, Katharine Abbott-Banner, Ken B. Newman · Pulmonary Pharmacology & Therapeutics · 2019 · 45 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls

Simon Lea, Hannah Metcalfe, Jonathan Plumb et al. · International Journal of COPD · 2016 · 23 citations · Full text

Medicine, Biochemistry, Pathology +17

Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study

Jagtar Singh Nijjar, Katharine Abbott-Banner, Yolanda Alvarez et al. · Annals of the Rheumatic Diseases · 2024 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11